Market Analysis: Global Surgical Site Infection Control Market
Global Surgical Site Infection Control Market is expected to rise from its initial estimated value of USD 4.07 billion to an estimated value of USD 6.47 billion by 2026, registering a CAGR of 5.97% in the forecast period of 2019-2026. This rise in market value can be attributed to the development and advancements of technologies resulting in innovative product offerings.
Few of the major competitors currently working in the surgical site infection control market are 3M; BD; STERIS plc; Johnson & Johnson Services, Inc.; Covalon Technologies Ltd.; SSIP, LLC; Stryker; Mölnlycke Health Care AB; Prescient Surgical; AMERICAN POLYFILM, INC.; PAUL HARTMANN AG; Medtronic; bioMérieux SA; LAC-MAC LIMITED; Getinge AB; Belimed; ANSELL LTD.; Pacon Manufacturing and KCWW.
Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-surgical-site-infection-control-market
Market Definition: Global Surgical Site Infection Control Market
Surgical site infections are caused when harmful bacteria or infection enters the incision or wound where the surgery is being carried out. These infections can be prevented with the usage of certain specifically designed medical devices, accessories and guidelines that have undergone sterilization and cleansing. This prevention includes a number of processes and guidelines helping in avoidance of any life-threatening unfortunate events.
Growth in the number of surgical procedures caused due to the rise in geriatric population globally; this factor is expected to drive the growth of the market
Increasing awareness and concerns regarding hospital-acquired infections and surgical site infections amid growing prevalence for the same is expected to drive the growth of the market
Lack of awareness and information regarding the methods and prevention control processes available for surgical site infection control is restraining the growth of the market
Increasing cases of patients being treated at the outpatient clinics instead of undergoing surgeries is expected to hinder the growth of the market
Segmentation: Global Surgical Site Infection Control Market
By Type of Infection
Deep Incisional Surgical Site Infection (SSI)
Organ or Space Surgical Site Infection (SSI)
Superficial Incisional Surgical Site Infection (SSI)
Skin Preparation Solution
Manual Reprocessors Solution
Ambulatory Surgical Centers
Rest of South America
Rest of Europe
Rest of Asia-Pacific
Middle East & Africa
United Arab Emirates
Rest of Middle East & Africa
Get TOC of Full Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-surgical-site-infection-control-market
Key Developments in the Market:
In December 2017, Prescient Surgical announced that they had received 510(k) clearance from the US FDA for the commercialization of their medical device developed to prevent surgical site infections during abdominal surgeries. The device named as “CleanCision Wound Retraction and Protection System” which helps in continuous cleansing of bacteria during the course of the entire surgery
In March 2017, Mölnlycke Health Care AB announced the launch of various surgical site infection control & prevention solutions. They expanded their product offerings by introducing “Mepilex Border Post-Op” dressings, “Biogel PI Micro Indicator Underglove” & “Biogel PI Micro Overglove” and “HIBICLENS”
Global surgical site infection control market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of surgical site infection control market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.